AlphaFold predicted structure
ATRIP · Q8WXE1

Mean pLDDT
68.9/ 100
Low
791 residues
Confidence breakdown
- Very high(≥ 90)33%
- Confident(70–90)25%
- Low(50–70)8%
- Very low(< 50)35%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
ATR interacting protein
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Breast cancer pertinent cancer susceptibility
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedFamilial breast cancer
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownIUGR and IGF abnormalities
BIALLELIC, autosomal or pseudoautosomalMonogenic short stature
BIALLELIC, autosomal or pseudoautosomalSevere microcephaly
BIALLELIC, autosomal or pseudoautosomalAicardi-Goutieres syndrome 1
retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations
chilblain lupus 1
systemic lupus erythematosus
Seckel syndrome
microcephalic primordial dwarfism
chilblain lupus
hereditary disease
Aicardi-Goutieres syndrome
neurodegenerative disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
ATR-interacting protein
Required for checkpoint signaling after DNA damage. Required for ATR expression, possibly by stabilizing the protein
ATRIP · Q8WXE1

Mean pLDDT
68.9/ 100
Low
791 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0